A 12 week, double-blind, placebo-controlled, parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from posttraumatic stress disorder

Authors
Category Primary study
UnpublishedInformation reported in a systematic review
Year 2020
This article has no abstract
Epistemonikos ID: b803f7beb2a78260467ec572af7343d7ae47819d
First added on: May 25, 2017